BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23931957)

  • 21. Problematising LGBTIQ drug use, governing sexuality and gender: A critical analysis of LGBTIQ health policy in Australia.
    Pienaar K; Murphy DA; Race K; Lea T
    Int J Drug Policy; 2018 May; 55():187-194. PubMed ID: 29395699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Keeping a lid on it': Exploring 'problematisations' of prescribed medication in prisons in the UK.
    Duke K; Trebilcock J
    Int J Drug Policy; 2022 Feb; 100():103515. PubMed ID: 34798433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National drug policy: implications of the 'tough on drugs' ideology.
    Norman R
    Collegian; 2001 Oct; 8(4):22-6. PubMed ID: 15484689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rethinking 'flexibilities' in the international drug control system-Potential, precedents and models for reforms.
    Collins J
    Int J Drug Policy; 2018 Oct; 60():107-114. PubMed ID: 28129946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The change of the health insurance policy and social welfare discourse in 1970s].
    Hwang BJ
    Uisahak; 2011 Dec; 20(2):425-62. PubMed ID: 22343702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of substance use and treatment from Australia.
    Haber PS; Day CA
    Subst Abus; 2014; 35(3):304-8. PubMed ID: 24853496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A perspective on Australia's National Medicines Policy.
    Tett SE
    Can J Clin Pharmacol; 2004; 11(1):e28-38. PubMed ID: 15226524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimizing drug-related harm in Australia-Australia's National Drug Strategy.
    Wares MC
    Drug Alcohol Rev; 1994; 13(1):87-92. PubMed ID: 16840122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Producing the vulnerable subject in English drug policy.
    Brown K; Wincup E
    Int J Drug Policy; 2020 Jun; 80():102525. PubMed ID: 31395470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical examination of the definition of 'psychoactive effect' in Australian drug legislation.
    Barratt MJ; Seear K; Lancaster K
    Int J Drug Policy; 2017 Feb; 40():16-25. PubMed ID: 27884504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Worth the test?' Pragmatism, pill testing and drug policy in Australia.
    Groves A
    Harm Reduct J; 2018 Apr; 15(1):12. PubMed ID: 29631613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing public health policy: three approaches.
    Coveney J
    Health Promot Pract; 2010 Jul; 11(4):515-21. PubMed ID: 18515504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
    Morgan S; McMahon M; Greyson D
    Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'We are still obsessed by this idea of abstinence': A critical analysis of UK news media representations of proposals to introduce drug consumption rooms in Glasgow, UK.
    Atkinson AM; McAuley A; Trayner KMA; Sumnall HR
    Int J Drug Policy; 2019 Jun; 68():62-74. PubMed ID: 31003193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voluntary food fortification policy in Australia: did 'formal' stakeholder consultation influence the outcome?
    Ashton B; Star C; Lawrence M; Coveney J
    Health Promot Int; 2021 Oct; 36(5):1393-1402. PubMed ID: 33550375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical analysis of the Australian Defence Force policy on maternal health care.
    Montalban M
    Aust N Z J Public Health; 2017 Aug; 41(4):399-404. PubMed ID: 28370902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Making change happen: a case study of the successful establishment of a peer-administered naloxone program in one Australian jurisdiction.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Sep; 25(5):985-91. PubMed ID: 24630077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The problematization of child sexual abuse in policy and law: The Indonesian example.
    Wismayanti YF; O'Leary P; Tilbury C; Tjoe Y
    Child Abuse Negl; 2021 Aug; 118():105157. PubMed ID: 34146965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.